Objective: To determine the views of people with multiple sclerosis (MS) and professionals in relation to confidentiality, consent and access to data within a proposed MS register in the UK.
Design: Qualitative study using focus groups (10) and interviews (13).
Setting: England and Northern Ireland.
Participants: 68 people with MS, neurologists, MS nurses, health services management professionals, researchers, representatives from pharmaceutical companies and social care professionals.
Results: People with MS expressed open and altruistic views towards the use of their personal information to facilitate service provision and research, placing trust in responsible guardianship and legitimate use of their information. Participant’s proposed that people with MS should be able to select their individual level of involvement in a register using levels of consent. It was agreed that access to the register should be governed by a guardianship committee composed of a range of stakeholders. People with MS did not wish their details to be used by marketing agencies and did not consider this a legitimate use of their data. Whilst participants were positive of the role a register could play in promoting research, participants felt that access to data by pharmaceutical industries should be administered by the guardianship committee. People with MS are concerned should their employers be able to access their personal information. Professionals were more cautious than people with MS in their approach to the use of patient personal data within a register.
Conclusions: Whilst all stakeholders were positive of the benefits of an MS register, development of such a resource must incorporate robust data security and guardianship measures in order to ensure that, whilst opportunities are maximised, risks to the privacy of individuals and legal challenges to professionals are avoided.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Funding: The Multiple Sclerosis Society of Great Britain
Competing interests: None.
Ethics approval: Ethics approval was received from Leeds West NHS research ethics committee.
Read the full text or download the PDF:
Other content recommended for you
- In response to Ballantyne and Schaefer’s ‘Consent and the ethical duty to participate in health data research’
- Extracting information from hospital records: what patients think about consent
- The governance of personal data for COVID-19 response: perspective from the Access to COVID-19 Tools Accelerator
- Patients' consent preferences for research uses of information in electronic medical records: interview and survey data
- Public attitudes to the use in research of personal health information from general practitioners' records: a survey of the Irish general public
- Assessing data protection and governance in health information systems: a novel methodology of Privacy and Ethics Impact and Performance Assessment (PEIPA)
- Consent and the ethical duty to participate in health data research
- The social licence for research: why care.data ran into trouble
- Public good, personal privacy: a citizens' deliberation about using medical information for pharmacoepidemiological research
- Impact of privacy legislation on the number and characteristics of people who are recruited for research: a randomised controlled trial